Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Assembly Biosciences (NQ: ASMB )

1.650 UNCHANGED
Streaming Delayed Price Updated: 12:30 PM EST, Feb 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 53,732
Open 1.640
Bid (Size) 1.640 (5)
Ask (Size) 1.650 (1)
Prev. Close 1.650
Today's Range 1.620 - 1.650
52wk Range 0.8200 - 2.420
Shares Outstanding 48,779,985
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Assembly Biosciences Shares Gain After Promising Early Cut Data From HBV Infection Programs
Assembly Biosciences Inc (NASDAQ: ASMB) announced interim efficacy, safety, and pharmacokinetic (PK) results from a Phase 1b study of ABI-H3733 (3733) and a Phase 1a study of ABI-4334 (4334). 
Via Benzinga
Assembly Biosciences Announces Promising Interim Results from Two Clinical Trials Evaluating Highly Potent Next-Generation Core Inhibitor Candidates ABI-H3733 and ABI-4334
From Assembly Biosciences, Inc.
Via Globe NewsWire

Performance

YTD
+23.13%
+23.13%
1 Month
+3.77%
+3.77%
3 Month
+20.44%
+20.44%
6 Month
-23.61%
-23.61%
1 Year
-4.07%
-4.07%

More News

Read More
Assembly Biosciences Doses First Subject in Phase 1a Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of Investigational Next Generation Core Inhibitor ABI-4334
From Assembly Biosciences, Inc.
Via Globe NewsWire
Disappointing Data Forces Assembly Bio Stop Combo Trial For HBV Infection
Via Benzinga
Assembly Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights and Announces Upcoming Conference Participation
From Assembly Biosciences, Inc.
Via Globe NewsWire
Assembly Biosciences Presents New Data at AASLD The Liver Meeting® Highlighting Breadth of Virology Portfolio and Potential of Next-Generation Core Inhibitors in HBV
From Assembly Biosciences, Inc.
Via Globe NewsWire
NVIDIA To $140? Plus This Analyst Cuts PT On Assembly Biosciences By 82%
Via Benzinga
Assembly Biosciences to Present Data in Four Poster Presentations at Upcoming AASLD The Liver Meeting®
From Assembly Biosciences, Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022
Via Benzinga
Assembly Bio Announces Retirement of John G. McHutchison, AO, MD as CEO and Appoints Current President and COO Jason A. Okazaki as Successor
From Assembly Biosciences, Inc.
Via Globe NewsWire
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
Via Benzinga
7 Penny Stocks That Could Triple in 2022
Via InvestorPlace
Assembly Bio Commences Early-Stage Study of Drug to Treat Hepatitis B Viral Infection
Via Benzinga
The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine
Via Benzinga
Week In Review: I-Mab Files For Hong Kong SPAC IPO To Acquire Life Science Company
Via Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2021
Via Benzinga
Mid-Afternoon Market Update: Dow Rises 90 Points; Kirkland's Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Via Benzinga
Dow Up Triple Digits, Poised to Snap Three-Day Skid
Via Talk Markets
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
65 Biggest Movers From Yesterday
Via Benzinga
Mid-Day Market Update: Crude Oil Jumps Over 2%; Assembly Biosciences Shares Plunge
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.